Aerovate Therapeutics, Inc.
Total Trades
168
Buys
1
Sells
87
Largest Trade
$1M+
Insiders
8
Institutional Funds
10
Inst. Value
$1M+
Activist Filings
18
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director | BUY | $1M+ | 928K | $1.67 | Jun 20, 2024 |
| Eldridge George A | SEE REMARKS | SELL | $100K–$500K | 15K | $25.03 | Jun 14, 2024 |
| Eldridge George A | SEE REMARKS | EXERCISE | $15K–$50K | 15K | $2.14 | Jun 14, 2024 |
| Verwijs Marinus | CHIEF TECHNICAL OF… | SELL | $100K–$500K | 11K | $25.00 | Jun 14, 2024 |
| Verwijs Marinus | CHIEF TECHNICAL OF… | EXERCISE | $100K–$500K | 11K | $14.59 | Jun 14, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | SELL | $100K–$500K | 6K | $24.50 | Jun 14, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | EXERCISE | $1K–$15K | 6K | $2.14 | Jun 14, 2024 |
| Verwijs Marinus | CHIEF TECHNICAL OF… | SELL | $15K–$50K | 2K | $21.02 | May 3, 2024 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OF… | SELL | $100K–$500K | 11K | $20.34 | May 3, 2024 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OF… | EXERCISE | $15K–$50K | 10K | $2.14 | May 3, 2024 |
| Dake Benjamin T | SEE REMARKS | EXERCISE | $1K–$15K | 7K | $2.14 | Apr 19, 2024 |
| Dake Benjamin T | SEE REMARKS | SELL | $100K–$500K | 7K | $22.37 | Apr 19, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | SELL | $50K–$100K | 4K | $22.38 | Apr 19, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | EXERCISE | $1K–$15K | 4K | $1.74 | Apr 19, 2024 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OF… | SELL | $100K–$500K | 10K | $24.70 | Apr 18, 2024 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OF… | EXERCISE | $15K–$50K | 10K | $2.14 | Apr 18, 2024 |
| Eldridge George A | SEE REMARKS | SELL | $100K–$500K | 8K | $26.85 | Apr 12, 2024 |
| Eldridge George A | SEE REMARKS | EXERCISE | $15K–$50K | 8K | $2.14 | Apr 12, 2024 |
| GRAYZEL DAVID S. | Director | SELL | $100K–$500K | 12K | $28.15 | Apr 11, 2024 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OF… | SELL | $100K–$500K | 10K | $30.00 | Apr 3, 2024 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OF… | EXERCISE | $15K–$50K | 10K | $2.14 | Apr 3, 2024 |
| Dake Benjamin T | SEE REMARKS | EXERCISE | $15K–$50K | 3K | $10.61 | Apr 3, 2024 |
| Dake Benjamin T | SEE REMARKS | SELL | $100K–$500K | 3K | $31.97 | Apr 3, 2024 |
| Verwijs Marinus | CHIEF TECHNICAL OF… | EXERCISE | $50K–$100K | 5K | $14.59 | Apr 3, 2024 |
| Verwijs Marinus | CHIEF TECHNICAL OF… | SELL | $100K–$500K | 5K | $29.19 | Apr 3, 2024 |
| Eldridge George A | SEE REMARKS | EXERCISE | $15K–$50K | 12K | $2.14 | Apr 3, 2024 |
| Eldridge George A | SEE REMARKS | SELL | $100K–$500K | 12K | $31.23 | Apr 3, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | EXERCISE | $15K–$50K | 9K | $2.14 | Apr 1, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | SELL | $100K–$500K | 9K | $29.50 | Apr 1, 2024 |
| Dake Benjamin T | SEE REMARKS | EXERCISE | $100K–$500K | 11K | $10.61 | Mar 28, 2024 |
| Dake Benjamin T | SEE REMARKS | SELL | $100K–$500K | 11K | $27.97 | Mar 28, 2024 |
| Dake Benjamin T | SEE REMARKS | EXERCISE | $15K–$50K | 3K | $10.61 | Mar 27, 2024 |
| Dake Benjamin T | SEE REMARKS | SELL | $50K–$100K | 3K | $28.01 | Mar 27, 2024 |
| Verwijs Marinus | CHIEF TECHNICAL OF… | EXERCISE | $50K–$100K | 5K | $14.59 | Mar 20, 2024 |
| Verwijs Marinus | CHIEF TECHNICAL OF… | SELL | $100K–$500K | 5K | $26.08 | Mar 20, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | EXERCISE | $1K–$15K | 7K | $1.91 | Mar 20, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | SELL | $100K–$500K | 7K | $25.87 | Mar 20, 2024 |
| Dake Benjamin T | SEE REMARKS | SELL | $500K+ | 35K | $25.90 | Mar 20, 2024 |
| Dake Benjamin T | SEE REMARKS | EXERCISE | $100K–$500K | 35K | $5.64 | Mar 20, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | EXERCISE | <$1K | 511 | $1.74 | Feb 27, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | SELL | $1K–$15K | 511 | $19.50 | Feb 27, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | EXERCISE | $1K–$15K | 3K | $1.74 | Feb 22, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | SELL | $50K–$100K | 3K | $20.23 | Feb 22, 2024 |
| NIVEN RALPH | CHIEF SCIENTIFIC O… | EXERCISE | $1K–$15K | 5K | $2.02 | Feb 7, 2024 |
| NIVEN RALPH | CHIEF SCIENTIFIC O… | SELL | $50K–$100K | 5K | $17.45 | Feb 7, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | EXERCISE | $1K–$15K | 4K | $1.74 | Jan 19, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | SELL | $50K–$100K | 4K | $19.50 | Jan 19, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | SELL | $1K–$15K | 125 | $24.50 | Dec 29, 2023 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | EXERCISE | <$1K | 125 | $2.14 | Dec 29, 2023 |
| Gillies Hunter | CHIEF MEDICAL OFFI… | SELL | $50K–$100K | 4K | $19.50 | Dec 22, 2023 |
Institutional Ownership
13F filings as of Mar 31, 2025 · 10 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 362K | $500K+ | SH |
| BlackRock, Inc. | 36K | $50K–$100K | SH |
| RHUMBLINE ADVISERS | 23K | $50K–$100K | SH |
| Bank of New York Mellon Corp | 5K | $1K–$15K | SH |
| NEW YORK STATE COMMON RETIREMENT FUND | 4K | $1K–$15K | SH |
| CWM, LLC | 2K | $1K–$15K | SH |
| NISA INVESTMENT ADVISORS, LLC | 868 | $1K–$15K | SH |
| AMALGAMATED BANK | 347 | $1K–$15K | SH |
| ROTHSCHILD INVESTMENT LLC | 230 | <$1K | SH |
| Capital Advisors, Ltd. LLC | 8 | N/A | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Nov 14, 2024
2.2%
629K shares
SC 13D/A · Jun 20, 2024
32.0%
9.2M shares
SC 13D/A · Apr 30, 2024
28.9%
8.3M shares
Sofinnova Venture Partners X, L.P. (“SVP X”)
SC 13D/A · Feb 21, 2024
9.0%
3.8M shares
SC 13G/A · Feb 14, 2024
0.0%
6 shares
SC 13G/A · Feb 14, 2024
6.1%
1.7M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2024
0.0%
0 shares
SC 13D/A · Jun 27, 2023
30.0%
8.3M shares
SC 13G/A · Feb 14, 2023
8.0%
2.0M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2023
3.0%
745K shares
SC 13G/A · Feb 14, 2023
6.4%
6 shares
Sofinnova Venture Partners X, L.P. (“SVP X”)
SC 13D/A · Feb 4, 2023
15.3%
3.8M shares
SC 13D/A · Dec 15, 2022
8.2%
2.0M shares
SC 13D/A · Jul 20, 2022
9.5%
2.3M shares
SC 13D/A · May 5, 2022
10.8%
2.6M shares
SC 13G · Feb 14, 2022
7.5%
1.8M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2022
2.5%
619K shares
SC 13G/A · Feb 14, 2022
6.5%
6 shares